Difficult to answer of course. However, there's still execution risk in ROW and NNZ. Interestingly, the valuation model suggests NA rights are worth circa $2bn. So, market seems to only reflect what's 'in the bag' ie NA rights.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-4550
-
- There are more pages in this discussion • 6,317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$21.20 |
Change
0.750(3.67%) |
Mkt cap ! $2.613B |
Open | High | Low | Value | Volume |
$20.56 | $21.23 | $20.54 | $1.786M | 85.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 291 | $21.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.20 | 461 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 253 | 21.110 |
4 | 165 | 21.100 |
3 | 291 | 21.090 |
6 | 399 | 21.080 |
4 | 370 | 21.070 |
Price($) | Vol. | No. |
---|---|---|
21.150 | 125 | 1 |
21.160 | 540 | 6 |
21.170 | 385 | 4 |
21.180 | 254 | 3 |
21.190 | 354 | 4 |
Last trade - 10.37am 16/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online